These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9205501

  • 1. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients.
    Bernard P, Bedane C, Bonnetblanc JM.
    Br J Dermatol; 1997 May; 136(5):694-8. PubMed ID: 9205501
    [Abstract] [Full Text] [Related]

  • 2. [Survival prognosis in pemphigoid. A cohort analysis of 78 patients].
    Bernard P, Enginger V, Venot J, Bedane C, Bonnetblanc JM.
    Ann Dermatol Venereol; 1995 May; 122(11-12):751-7. PubMed ID: 8729818
    [Abstract] [Full Text] [Related]

  • 3. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M, Hashimoto T, Dykes PJ, Nishikawa T.
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
    Bernard P, Reguiai Z, Tancrède-Bohin E, Cordel N, Plantin P, Pauwels C, Vaillant L, Grange F, Richard-Lallemand MA, Sassolas B, Roujeau JC, Lok C, Picard-Dahan C, Chosidow O, Vitry F, Joly P.
    Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
    Desai N, Allen J, Ali I, Venning V, Wojnarowska F.
    Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects.
    Wieland CN, Comfere NI, Gibson LE, Weaver AL, Krause PK, Murray JA.
    Arch Dermatol; 2010 Jan; 146(1):21-5. PubMed ID: 20083688
    [Abstract] [Full Text] [Related]

  • 9. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M.
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [Abstract] [Full Text] [Related]

  • 10. Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis.
    Yayli S, Pelivani N, Beltraminelli H, Wirthmüller U, Beleznay Z, Horn M, Borradori L.
    Br J Dermatol; 2011 Nov; 165(5):1133-7. PubMed ID: 21711326
    [Abstract] [Full Text] [Related]

  • 11. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
    Izumi R, Fujimoto M, Yazawa N, Nakashima H, Asashima N, Watanabe R, Kuwano Y, Kurokawa M, Hashimoto T, Tamaki K.
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
    [Abstract] [Full Text] [Related]

  • 12. Prediction of survival for patients with bullous pemphigoid: a prospective study.
    Joly P, Benichou J, Lok C, Hellot MF, Saiag P, Tancrede-Bohin E, Sassolas B, Labeille B, Doutre MS, Gorin I, Pauwels C, Chosidow O, Caux F, Estève E, Dutronc Y, Sigal M, Prost C, Maillard H, Guillaume JC, Roujeau JC.
    Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914
    [Abstract] [Full Text] [Related]

  • 13. Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid.
    Joly P, Gilbert D, Thomine E, Delpech A, Courville P, Young P, Le Corvaisier C, Lauret P, Tron F.
    Arch Dermatol; 1997 Jun; 133(6):719-24. PubMed ID: 9197825
    [Abstract] [Full Text] [Related]

  • 14. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
    Barnadas MA, Rubiales MV, González MJ, Puig L, García P, Baselga E, Pujol R, Alomar A, Gelpí C.
    Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Two cases of childhood bullous pemphigoid.
    Toyama T, Nakamura K, Kuramochi A, Ohyama B, Hashimoto T, Tsuchida T.
    Eur J Dermatol; 2009 Dec; 19(4):368-71. PubMed ID: 19451055
    [Abstract] [Full Text] [Related]

  • 17. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
    Shinojima Y, Ochiai T, Kawamura A, Arakawa H, Fukuda K, Hashimoto T.
    Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A, Scheckenbach C, Georgi M, Hagel C, Arndt R, Christophers E, Bröcker EB, Zillikens D.
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.